Business Case

Analyzed competitive scenarios and prescriber behavior to understand potential place in therapy, net patient potential, and payer reactions to identify minimum viable payer agreements

A large pharmaceutical company sought insights into their product’s potential place in therapy amidst competitive scenarios in order to develop a more informed launch strategy. LSC conducted epidemiological research, analyzed prescriber behaviors, and explored payer reactions to determine both the “gross potential” by therapy line and the net patient potential. The outcome was a refined clinical value proposition with expected line of therapy, suitable pricing thresholds by line of therapy and clinical benefit. The final report guided the initiation of early access programs and shaped the blueprint for minimum viable managed entry agreements.